A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to research supported by NIH's National Eye Institute. The findings suggest a way forward for developing neuroprotective therapies for glaucoma, a leading…
Read More
Aflibercept Won’t Help Vision in Early Diabetic Retinopathy
Intravitreal injections with aflibercept (Eylea) don’t improve the visual acuity of people with nonproliferative diabetic retinopathy (NPDR), researchers say. The treatments do reduce the risk for center-involved diabetic macular edema and proliferative diabetic retinopathy, however, said Adam R. Glassman, MS,…
Read More
Emerging Gene Therapy Offers Window Into Potential Costs of New Class of Therapies
(Reuters Health) – The budget impact to Medicaid of gene therapy to treat severe sickle cell disease offers a window on the potential costs of this emerging class of million-dollar treatments, and requires payers to think about how to ensure…
Read More
New gene therapy developed for treating eye disease that leads to a progressive loss of vision
Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the globe. The study,…
Read More